Literature DB >> 6500606

Elevated overall rates of transmethylation in cell lines from diverse human tumors.

P H Stern, R M Hoffman.   

Abstract

In a study of a diverse set of human tumor cell lines previously shown to all have a defect in methionine metabolism (Stern, P. H., Wallace, C.D. and Hoffman, R.M., J. Cellular Physiology 119, 29-34, 1984), we demonstrate in this report that all have enhanced overall rates of transmethylation compared to normal human fibroblasts. Transmethylation rates were measured by blocking S-adenosylhomocysteine hydrolase and measuring the AdoHcy which accumulates as a result of transmethylation. The enhanced transmethylation rates may be the basis of the above-mentioned defects in methionine metabolism previously reported in human tumor cells, including the basis of the inability of the majority of the tumor cells to grow when methionine is replaced by homocysteine. The excess and unbalanced tRNA methylation observed for the last 25 years in many types of cancer may be at least in part explained by our results of elevated rates of overall transmethylation in cancer cells. The alteration of such a fundamental process as transmethylation in cancer may be indicative of its importance in the oncogenic process.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6500606     DOI: 10.1007/bf02619617

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  27 in total

1.  Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice.

Authors:  D D Mickey; K R Stone; H Wunderli; G H Mickey; R T Vollmer; D F Paulson
Journal:  Cancer Res       Date:  1977-11       Impact factor: 12.701

2.  Characterization of a newly derived human sarcoma cell line (HT-1080).

Authors:  S Rasheed; W A Nelson-Rees; E M Toth; P Arnstein; M B Gardner
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

3.  Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

Authors:  J Bubeník; M Baresová; V Viklický; J Jakoubková; H Sainerová; J Donner
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

4.  Human sarcoma cells in culture. Identification by colony-forming ability on monolayers of normal cells.

Authors:  S A Aaronson; G J Todaro; A E Freeman
Journal:  Exp Cell Res       Date:  1970-07       Impact factor: 3.905

Review 5.  Methionine dependence in cancer cells - a review.

Authors:  R M Hoffman
Journal:  In Vitro       Date:  1982-05

6.  The preparation of [35S]homocysteine thiolactone free of [35S]methionine.

Authors:  P H Stern; J O Mecham; R M Hoffman
Journal:  J Biochem Biophys Methods       Date:  1982-12

7.  Extent of DNA methylation in human tumor cells.

Authors:  E S Diala; M S Cheah; D Rowitch; R M Hoffman
Journal:  J Natl Cancer Inst       Date:  1983-10       Impact factor: 13.506

8.  Changes in tRNA methyltransferase activity and cellular S-adenosylmethionine content following methionine deprivation.

Authors:  M J Tisdale
Journal:  Biochim Biophys Acta       Date:  1980-09-19

9.  The metabolic defect of methionine dependence occurs frequently in human tumor cell lines.

Authors:  J O Mecham; D Rowitch; C D Wallace; P H Stern; R M Hoffman
Journal:  Biochem Biophys Res Commun       Date:  1983-12-16       Impact factor: 3.575

10.  Measurements of S-adenosylmethionine and L-homocysteine metabolism in cultured human lymphoid cells.

Authors:  D C German; C A Bloch; N M Kredich
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

View more
  36 in total

1.  Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.

Authors:  Kei Kawaguchi; Kentaro Miyake; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Thinzar M Lwin; Takashi Higuchi; Tasuku Kiyuna; Masuyo Miyake; Hiromichi Oshiro; Michael Bouvet; Michiaki Unno; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-05-21       Impact factor: 4.534

2.  Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.

Authors:  Kei Kawaguchi; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Tasuku Kiyuna; Kentaro Miyake; Masuyo Miyake; Bartosz Chmielowski; Scott D Nelson; Tara A Russell; Sarah M Dry; Yunfeng Li; Arun S Singh; Mark A Eckardt; Michiaki Unno; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-03-19       Impact factor: 4.534

Review 3.  The wayward methyl group and the cascade to cancer.

Authors:  Robert M Hoffman
Journal:  Cell Cycle       Date:  2017-03-20       Impact factor: 4.534

Review 4.  The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Authors:  Giovanni Cammaroto; Natale Quartuccio; Alessandro Sindoni; Francesca Di Mauro; Federico Caobelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

5.  A study on the prognostic evaluation of carbon ion radiotherapy for head and neck adenocarcinoma with C-11 methionine PET.

Authors:  Mitsuhiko Hasebe; Kyosan Yoshikawa; Seiya Ohashi; Sachiko Toubaru; Koji Kawaguchi; Junichi Sato; Junetsu Mizoe; Hirohiko Tsujii
Journal:  Mol Imaging Biol       Date:  2010-10       Impact factor: 3.488

6.  Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging.

Authors:  Shuya Yano; Kiyoto Takehara; Ming Zhao; Yuying Tan; Qinghong Han; Shukuan Li; Michael Bouvet; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Cell Cycle       Date:  2016-05-06       Impact factor: 4.534

Review 7.  Adenoid cystic carcinoma: focus on heavy ion therapy and molecular imaging.

Authors:  Angelo Castello; Laura Olivari; Egesta Lopci
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-02-05

8.  Carbon-11-methionine positron emission tomography imaging of chordoma.

Authors:  Hong Zhang; Kyosan Yoshikawa; Katsumi Tamura; Kenji Sagou; Mei Tian; Tetsuya Suhara; Susumu Kandatsu; Kazutoshi Suzuki; Shuji Tanada; Hirohiko Tsujii
Journal:  Skeletal Radiol       Date:  2004-07-28       Impact factor: 2.199

9.  Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung metastasis in a patient-derived orthotopic xenograft (PDOX) mouse model: decoy, trap and kill chemotherapy moves toward the clinic.

Authors:  Kentaro Igarashi; Kei Kawaguchi; Tasuku Kiyuna; Kentaro Miyake; Masuyo Miyake; Shukuan Li; Qinghong Han; Yuying Tan; Ming Zhao; Yunfeng Li; Scott D Nelson; Sarah M Dry; Arun S Singh; Irmina A Elliott; Tara A Russell; Mark A Eckardt; Norio Yamamoto; Katsuhiro Hayashi; Hiroaki Kimura; Shinji Miwa; Hiroyuki Tsuchiya; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-04-10       Impact factor: 4.534

10.  De novo engineering of a human cystathionine-γ-lyase for systemic (L)-Methionine depletion cancer therapy.

Authors:  Everett Stone; Olga Paley; Jian Hu; Barbara Ekerdt; Nai-Kong Cheung; George Georgiou
Journal:  ACS Chem Biol       Date:  2012-09-21       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.